Acute phosphate nephropathy

A cause of chronic kidney disease

Jessica Weiss, Micah L. Thorp

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Acute phosphate nephropathy occurs whenever a patient with renal dysfunction is exposed to high doses of phosphate. Bowel purgative agents are a common source of high doses of sodium phosphate and are widely used as bowel preparation agents prior to colonoscopy due to their efficacy and tolerability. Oral sodium phosphate (OSP) preparations used to prepare patients for colonoscopy may be a cause of acute and chronic kidney disease (CKD). CKD associated with OSP agents is the result of nephrocalcinosis, or calcium phosphorus crystal deposition in the renal parenchyma leading to interstitial disease. It is often irreversible and progressive in nature. The authors report a case of CKD which presented with non-specific symptoms weeks after use of an OSP agent as part of a bowel preparation regimen. Renal biopsy confirmed nephrocalcinosis.

Original languageEnglish (US)
JournalBMJ Case Reports
DOIs
StatePublished - 2011

Fingerprint

Chronic Renal Insufficiency
Phosphates
Nephrocalcinosis
Colonoscopy
Kidney
Cathartics
Phosphorus
Calcium
Biopsy
sodium phosphate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Acute phosphate nephropathy : A cause of chronic kidney disease. / Weiss, Jessica; Thorp, Micah L.

In: BMJ Case Reports, 2011.

Research output: Contribution to journalArticle

@article{12626a122b464384a746243d9b3d7bdf,
title = "Acute phosphate nephropathy: A cause of chronic kidney disease",
abstract = "Acute phosphate nephropathy occurs whenever a patient with renal dysfunction is exposed to high doses of phosphate. Bowel purgative agents are a common source of high doses of sodium phosphate and are widely used as bowel preparation agents prior to colonoscopy due to their efficacy and tolerability. Oral sodium phosphate (OSP) preparations used to prepare patients for colonoscopy may be a cause of acute and chronic kidney disease (CKD). CKD associated with OSP agents is the result of nephrocalcinosis, or calcium phosphorus crystal deposition in the renal parenchyma leading to interstitial disease. It is often irreversible and progressive in nature. The authors report a case of CKD which presented with non-specific symptoms weeks after use of an OSP agent as part of a bowel preparation regimen. Renal biopsy confirmed nephrocalcinosis.",
author = "Jessica Weiss and Thorp, {Micah L.}",
year = "2011",
doi = "10.1136/bcr.04.2010.2876",
language = "English (US)",
journal = "BMJ Case Reports",
issn = "1757-790X",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Acute phosphate nephropathy

T2 - A cause of chronic kidney disease

AU - Weiss, Jessica

AU - Thorp, Micah L.

PY - 2011

Y1 - 2011

N2 - Acute phosphate nephropathy occurs whenever a patient with renal dysfunction is exposed to high doses of phosphate. Bowel purgative agents are a common source of high doses of sodium phosphate and are widely used as bowel preparation agents prior to colonoscopy due to their efficacy and tolerability. Oral sodium phosphate (OSP) preparations used to prepare patients for colonoscopy may be a cause of acute and chronic kidney disease (CKD). CKD associated with OSP agents is the result of nephrocalcinosis, or calcium phosphorus crystal deposition in the renal parenchyma leading to interstitial disease. It is often irreversible and progressive in nature. The authors report a case of CKD which presented with non-specific symptoms weeks after use of an OSP agent as part of a bowel preparation regimen. Renal biopsy confirmed nephrocalcinosis.

AB - Acute phosphate nephropathy occurs whenever a patient with renal dysfunction is exposed to high doses of phosphate. Bowel purgative agents are a common source of high doses of sodium phosphate and are widely used as bowel preparation agents prior to colonoscopy due to their efficacy and tolerability. Oral sodium phosphate (OSP) preparations used to prepare patients for colonoscopy may be a cause of acute and chronic kidney disease (CKD). CKD associated with OSP agents is the result of nephrocalcinosis, or calcium phosphorus crystal deposition in the renal parenchyma leading to interstitial disease. It is often irreversible and progressive in nature. The authors report a case of CKD which presented with non-specific symptoms weeks after use of an OSP agent as part of a bowel preparation regimen. Renal biopsy confirmed nephrocalcinosis.

UR - http://www.scopus.com/inward/record.url?scp=79956271371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956271371&partnerID=8YFLogxK

U2 - 10.1136/bcr.04.2010.2876

DO - 10.1136/bcr.04.2010.2876

M3 - Article

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

ER -